Northpond Ventures

Northpond Ventures is a venture capital firm founded in 2018 that invests in breakthrough science and technology, working with researchers, entrepreneurs and innovators to convert scientific discoveries into businesses and commercial products. Its stated purpose is the advancement of science for the benefit of humanity, and its approach combines venture investment with hands-on support for the companies it backs.

The firm's technical focus spans biotechnology, therapeutics, diagnostics, digital health, scientific tools and life sciences more broadly, with particular attention to translational research - the process of moving findings from the laboratory towards clinical or commercial application. Portfolio and investment activity is oriented towards early-stage companies and ventures originating in research settings.

Beyond investment, Northpond Ventures operates Northpond Labs, a platform supporting translational research, company formation and commercialisation. The initiative includes collaboration with academic institutions and scientific entrepreneurs, reflecting a model in which the firm participates in venture creation rather than solely in financing.

Headquartered in Bethesda, Maryland, Northpond Ventures maintains additional offices in Cambridge, Massachusetts and San Francisco, California. The firm describes its culture as science-driven, entrepreneurial and collaborative, with an emphasis on supporting early-stage companies through a combination of capital and active involvement.